Indications and uses
relieves occasional constipation (irregularity) generally produces a bowel movement in 12-72 hours
relieves occasional constipation (irregularity) generally produces a bowel movement in 12-72 hours
MIX THIS PRODUCT (CHILD OR ADULT DOSE) WITH AT LEAST 8 OUNCES (A FULL GLASS) OF WATER OR OTHER FLUID. TAKING THIS PRODUCT WITHOUT ENOUGH LIQUID MAY CAUSE CHOKING. SEE CHOKING WARNING use product at the first sign of constipation or irregularity put one dose in a full glass of cold water stir briskly and drink promptly drinking another glass of water is helpful CITRUCEL Orange Age Dose adults and children 12 years ...
Methylcellulose (a non-allergenic fiber) 2 g
Methylcellulose (a non-allergenic fiber) 2 g
Bulk-forming fiber laxative
Choking: taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking. Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product, seek immediate medical attention.
In case of overdose, get medical help or contact a Poison Control Center right away.
CITRUCEL Orange
Age | Dose |
adults and children 12 years of age and over | start with 1 heaping tablespoon. Increase as needed, 1 heaping tablespoonat a time, up to 3 times per day. |
children 6 - 11 years of age | start with 2.5 level teaspoons. Increase as needed, 2.5 level teaspoonsat a time, up to 3 times per day. |
children under 6 years of age | consult a doctor |
CITRUCEL Sugar Free
Age | Dose |
adults and children 12 years of age and over | start with 1 rounded tablespoon. Increase as needed, 1 rounded tablespoonat a time, up to 3 times per day. |
children 6 - 11 years of age | start with 2 level teaspoons. Increase as needed, 2 level teaspoonsat a time, up to 3 times per day. |
children under 6 years of age | consult a doctor |
citric acid, dibasic calcium phosphate, FD&C yellow no. 6 lake, maltodextrin, orange flavors (natural and artificial), potassium citrate, riboflavin, soy lecithin, sucrose, titanium dioxide, tricalcium phosphate
aspartame, dibasic calcium phosphate, FD&C yellow no. 6 lake, malic acid, maltodextrin, orange flavors (natural and artificial), potassium citrate, riboflavin, soy lecithin
1-800-452-0051
TAMPER EVIDENT PACKAGE
DO NOT USE IF FOIL SEAL IS MISSING OR BROKEN.
GREAT TASTING
CITRUCEL
ORANGE
offers these great benefits:
*When Used As Directed.
**Based On Laboratory Testing. Individual Results May Vary.
DIRECTIONS FOR USE (NO SCOOP DOSING):

1. Fill glass with at least 8 oz. of cold water.

2. Measure heaping tablespoon of product (one dose) and stir product into water. Stir briskly and drink promptly.
TAMPER EVIDENT PACKAGE
DO NOT USE IF FOIL SEAL IS MISSING OR BROKEN.
GREAT TASTING ORANGE FLAVOR
CITRUCEL
SUGAR FREE
offers these great benefits:
*When Used As Directed.
**Based On Laboratory Testing. Individual Results May Vary.
DIRECTIONS FOR USE (NO SCOOP DOSING):

1. Fill glass with at least 8 oz. of cold water.

2. Measure rounded tablespoon of product (one dose) and stir product into water. Stir briskly and drink promptly.
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1868847 | CITRUCEL 2 GM Powder for Oral Suspension | PSN | 17 |
| 1868843 | methylcellulose 2 GM Powder for Oral Suspension | PSN | 17 |
| 1868847 | methylcellulose 2000 MG Powder for Oral Suspension [Citrucel] | SBD | 17 |
| 1868843 | methylcellulose 2000 MG Powder for Oral Suspension | SCD | 17 |
| 1868847 | Citrucel 2 GM Granules for Oral Suspension | SY | 17 |
| 1868847 | Citrucel 2 GM Powder for Oral Suspension | SY | 17 |
| 1868847 | Citrucel 2000 MG Powder for Oral Suspension | SY | 17 |
| 1868843 | methylcellulose 2 GM Granules for Oral Suspension | SY | 17 |
| 1868843 | methylcellulose 2 GM Powder for Oral Suspension | SY | 17 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906 | Product name | 7 | 20210625 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0135-0089-69 | CITRUCEL | 454 g in 1 BOTTLE | POWDER, FOR SOLUTION | 454 | 17 | |
| 0135-0089-71 | CITRUCEL | 850 g in 1 BOTTLE | POWDER, FOR SOLUTION | 850 | 17 | |
| 0135-0090-70 | CITRUCEL | 479 g in 1 BOTTLE | POWDER, FOR SOLUTION | 479 | 17 | |
| 0135-0090-74 | CITRUCEL | 907 g in 1 BOTTLE | POWDER, FOR SOLUTION | 907 | 17 | |
| 0135-0090-75 | CITRUCEL | 1191 g in 1 BOTTLE | POWDER, FOR SOLUTION | 1191 | 17 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0135-0089-69 | GM - Gram | 0135-0089 | 6ef4886b-287d-4d39-808c-ecab2773aa69 | 1 | 2012-07-24 |
| 0135-0089-71 | GM - Gram | 0135-0089 | 898fbf5c-06a8-4c13-a68e-74a65717444f | 1 | 2012-07-24 |
| 0135-0090-70 | GM - Gram | 0135-0090 | 00853d31-b9bc-4a2b-83fa-34968738e49d | 1 | 2013-02-13 |
| 0135-0090-74 | GM - Gram | 0135-0090 | 6393c8cb-0a1f-4f38-858b-174c8c8a36d5 | 1 | 2012-07-24 |
| 0135-0090-75 | GM - Gram | 0135-0090 | 73c4e040-c8cb-4aaa-a5d7-dd14cf81a715 | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| METHYLCELLULOSE (4000 MPA.S) | ACTIVE INGREDIENT | MRJ667KA5E | 6 | |
| METHYLCELLULOSE (4000 MPA.S) | ACTIVE MOIETY | MRJ667KA5E | 6 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | 6 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | 6 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 6 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | 6 | |
| MALIC ACID | INACTIVE INGREDIENT | 817L1N4CKP | 6 | |
| MALTODEXTRIN | INACTIVE INGREDIENT | 7CVR7L4A2D | 6 | |
| POTASSIUM CITRATE | INACTIVE INGREDIENT | EE90ONI6FF | 6 | |
| RIBOFLAVIN | INACTIVE INGREDIENT | TLM2976OFR | 6 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 6 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 6 | |
| TRICALCIUM PHOSPHATE | INACTIVE INGREDIENT | K4C08XP666 | 6 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0135-0089 | 0135-0089-69, 0135-0089-71 |
| 0135-0090 | 0135-0090-70, 0135-0090-74, 0135-0090-75 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | L11K75P92J | TABLET, COATED / ORAL | 333.3 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SUSPENSION / ORAL | 113 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, LIQUID FILLED / ORAL | 12 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET / ORAL | 320 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 24 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, COATED / ORAL | 5.6 mg | ||
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | L11K75P92J | TABLET, DELAYED RELEASE / ORAL | 2834 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | SOLUTION / ORAL | 1451 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | POWDER, FOR SUSPENSION / ORAL | 8000 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | NA | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | POWDER, FOR SOLUTION / ORAL | 233 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, EFFERVESCENT / ORAL | 14404 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 42 mg | ||
| RIBOFLAVIN | RIBOFLAVIN | TLM2976OFR | TABLET / ORAL | 0.03 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | GRANULE, FOR SUSPENSION / ORAL | 952 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, EFFERVESCENT / ORAL | 14404 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, EFFERVESCENT / ORAL | 14404 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | POWDER, FOR SOLUTION / ORAL | 233 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, CHEWABLE / ORAL | 292 mg | ||
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | L11K75P92J | CAPSULE / ORAL | 401 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET / ORAL | 320 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, ORALLY DISINTEGRATING / ORAL | 12 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED / ORAL | 17 mg | ||
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | L11K75P92J | TABLET, DELAYED RELEASE / ORAL | 2834 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE / ORAL | 55 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, CHEWABLE / ORAL | 292 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, EXTENDED RELEASE / ORAL | 3239 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | SUSPENSION / ORAL | 6040 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | PASTE / ORAL | 1050 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | POWDER, FOR SOLUTION / ORAL | 40 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | FILM, SOLUBLE / ORAL | 19 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 11 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / ORAL | 315 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / ORAL | 315 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, SOLUBLE / ORAL | 2 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | GRANULE, FOR SUSPENSION / ORAL | 952 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | FILM, SOLUBLE / ORAL | 19 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET / ORAL | 320 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | LOZENGE / ORAL | 175 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 24 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | NA | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | PASTE / ORAL | 1050 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | LOZENGE / ORAL | 175 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | POWDER, FOR SOLUTION / ORAL | 40 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, COATED / ORAL | 5.6 mg | ||
| MALIC ACID | MALIC ACID | 817L1N4CKP | POWDER, FOR SOLUTION / ORAL | 1230 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET / ORAL | 320 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE / ORAL | 55 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | POWDER, FOR SOLUTION / ORAL | 40 mg | ||
| MALIC ACID | MALIC ACID | 817L1N4CKP | POWDER, FOR SOLUTION / ORAL | 1230 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, CHEWABLE / ORAL | 292 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 11 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED PELLETS / ORAL | 4.4 mg | ||
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | L11K75P92J | TABLET, FILM COATED / ORAL | 1075 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / ORAL | 2 mg | ||
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | L11K75P92J | TABLET, EXTENDED RELEASE / ORAL | 360 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CITRUCEL | METHYLCELLULOSE | Haleon US Holdings LLC | 9d5f2244-a610-4d45-b6e8-e79bb17a558f | 2026-03-18 | Warnings | 0135-0089-71 0135-0090-74 0135-0089-69 0135-0090-70 0135-0090-75 0135-0090 0135-0089 00135008969 00135009070 00135008971 00135009075 00135009074 4d50ac6b-2405-defb-e063-6394a90aa71c 9d5f2244-a610-4d45-b6e8-e79bb17a558f |
Adverse event summaries are temporarily unavailable. Other product information remains available.